Maprimed Sa, based in Argentina, is a pharmaceutical company.
One of their notable products is ZOLEDRONIC ACID MONOHYDRATE (CODE 50787), with a corresponding US DMF Number 26067.
Remarkably, this DMF maintains an Active status since its submission on May 18, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 04, 2013, and payment made on December 19, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II